Svilen D.
- Country
- Bulgaria
- Department
- N/A
Research Overview
- Evaluation of Safety, Pharmacokinetics, and Efficacy of GS-5245 in Pediatric Patients with COVID-19: A Phase 2/3 Single-Arm, Open-Label Study
- A Phase 2 Dose Finding Study Evaluating the Safety and Efficacy of Linaclotide in Pediatric Subjects 6 Months to Less Than 2 Years of Age with Functional Constipation (FC).
- A Phase 3, Multicenter, Randomized, Double-blind, Parallel-group, Safety and Efficacy Study of Linaclotide versus Placebo in Pediatric Subjects, Ages 2 to 5 Years, with Functional Constipation (FC) with a 24-week Open-label Treatment Extension
Data & Insights
Has run more than one trial at 6 of 28 partner sites.
Specializations
Pediatric Gastroenterology
The investigator specializes in treating functional constipation in young pediatric populations, with particular focus on children from 6 months to 5 years of age. Their research encompasses therapeutic approaches for managing chronic gastrointestinal conditions in early childhood.
- Early Childhood Constipation Management
- Pediatric Functional Gastrointestinal Disorders
- Long-term Safety Assessment in Young Children
Their work is particularly focused on developing age-appropriate therapeutic solutions for very young patients with gastrointestinal disorders.
Pediatric Infectious Diseases
The investigator conducts research in pediatric COVID-19 treatment, focusing on developing therapeutic interventions for children and adolescents affected by the virus. Their work includes evaluation of novel therapeutic agents in pediatric populations.
- COVID-19 Treatment in Children
- Pediatric Pharmacokinetics
- Safety Assessment in Viral Infections
Their research contributes to understanding medication safety and efficacy in pediatric infectious disease treatment.
Pediatric Clinical Pharmacology
The investigator focuses on pharmacokinetic studies in pediatric populations, with emphasis on age-appropriate dosing and safety monitoring. Their expertise includes evaluating medication tolerability across different pediatric age groups.
- Age-specific Drug Response Assessment
- Pediatric Drug Safety Monitoring
- Therapeutic Dose Finding Studies
Their work encompasses careful evaluation of medication responses in various pediatric age groups.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.